r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

NK

Neil Kumar

Insider · Chief Executive Officer · BBIO

Neil Kumar files insider transactions with the SEC as a chief executive officer of BridgeBio Pharma (BBIO). We hold 16 disclosed purchases and sales filed since 22 June 2018, 2 of them in the last 90 days.

  • Files forBBIO
  • Disclosed buys and sells16 in all, 2 in the last 90 days
  • Last disclosure20 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 July 2019 — 19 August 2026Chief Executive Officer · BridgeBio Pharma (BBIO)435 Form 4 lines · source: SEC Form 4
  • Filed 16 June 2026 — 16 June 2026Director · BridgeBio Oncology Therapeutics (BBOT)1 Form 4 line · source: SEC Form 4
  • Filed 27 March 2026 — 27 March 2026Director · Maze Therapeutics (MAZE)2 Form 4 lines · source: SEC Form 4
  • Filed 22 June 2018 — 3 July 2019Chief Executive Officer · Eidos Therapeutics (EIDX)16 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.